Candel Therapeutics, Inc. (CADL)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-73.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $125.0K | $125.0K | $125.0K | — |
| Operating Income | -$48.27M | -$33.37M | -$38.39M | -$34.72M | -$25.73M | -$13.81M | — |
| Net Income | -$38.18M | -$55.18M | -$37.94M | -$18.79M | -$36.12M | -$17.68M | — |
| EPS (Diluted) | $-0.72 | $-1.74 | $-1.31 | $-0.65 | $-1.91 | — | — |
| Total Assets | $125.19M | $106.87M | $41.20M | $77.69M | $89.20M | $38.28M | — |
| Total Liabilities | $73.27M | $40.54M | $28.46M | $29.98M | $25.07M | $12.78M | — |
| Shareholders' Equity | $51.92M | $66.33M | $12.74M | $47.71M | $64.14M | -$23.56M | -$8.04M |
| Cash & Equivalents | $119.73M | $102.65M | $35.41M | $70.06M | $82.64M | $35.05M | — |
| Operating Cash Flow | -$38.31M | -$27.02M | -$34.24M | -$31.42M | -$22.22M | -$9.07M | — |
| Capital Expenditures | $587.0K | $16.0K | $457.0K | $1.30M | $1.83M | $1.48M | — |
| Shares Outstanding | 54.90M | 46.81M | 29.09M | 28.92M | 28.69M | 11.64M | — |